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Résumé en
anglais
Thiazolidinediones (TZDs) represent an interesting treatment of type 2 diabetes
mellitus. However, adverse effects such as heart problems and bone fractures have
already been reported. Previously, we reported that pioglitazone and rosiglitazone
induce osteocyte apoptosis and sclerostin up-regulation; however, the molecular
mechanisms leading to such effects are unknown. In this study, we found that TZDs
rapidly activated Erk1/2 and p38. These activations were mediated through Ras
proteins and GPR40, a receptor expressed on the surface of osteocytes. Activation
of this pathway led only to osteocyte apoptosis but not sclerostin up-regulation. On
the other hand, TZDs were capable of activating peroxisome proliferator-activated
receptor-γ, and activation of this signaling pathway led to sclerostin up-regulation
but not osteocyte apoptosis. This study demonstrates two distinct signaling
pathways activated in osteocytes in response to TZDs that could participate in the
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